Moderna will seek FDA emergency use authorization for its vaccine in kids under 6

Moderna said it plans to seek emergency use authorization from the U.S. Food and Drug Administration for its COVID-19 vaccine in children under age 6 "in the coming weeks."

The company released clinical trial data Wednesday showing neutralizing antibody levels were similar to those seen in adults.

The vaccine in children is a two-dose, 25-microgram shot, about a quarter of the dose used for adults, given 28 days apart.